Outcomes in moderate mixed aortic valve disease
Part of Heart & circulation clinical trials.
This study looks at people with a combination of moderate aortic stenosis and regurgitation, comparing them to those with severe aortic valve problems. It aims to understand outcomes and help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate aortic stenosis and regurgitation together
- Or you have severe aortic stenosis
- Or you have severe aortic regurgitation
- You have not had aortic valve surgery in the past
- No more than mild heart valve disease on the left side of your heart
- You do not have acute aortic regurgitation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and/or body signals (called biomarkers) to understand why aortic valve narrowing may worsen and what outcomes people have. You may be able to help researchers by undergoing regular heart care plus additional testing like MRI or CT if you qualify.
This research study is a registry that collects information about people with aortic stenosis, a condition where a heart valve becomes narrow. The goal is to learn more about how this condition is managed and to improve future care.
This trial compares two approaches for people with a leaking aortic valve but no symptoms: early surgery or careful monitoring (“watchful waiting”). It aims to see which strategy better prevents future heart problems and when surgery is most helpful.
This study looks at people who have two or more heart valve problems that are moderate to severe. It aims to learn more about this condition and how to best manage it.
This study follows people with moderate aortic valve disease to learn how their condition changes. It does not test a new treatment but will help doctors better understand the disease.
This study compares doing aortic valve replacement sooner versus waiting, in people with moderate aortic valve narrowing plus at least moderate leakage in the mitral valve. It aims to see which timing improves heart symptoms and outcomes while keeping treatment safe.
Hear when a new Mixed Aortic Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.